Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma
Introduction. Malignant Pleural Mesothelioma (MPM) is a rare disease, even less frequently described in minority patients. We used a large population-based dataset to study the role of race in MPM presentation, treatment, and survival. Methods. All cases of pathologically proven MPM were identified...
Main Authors: | , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430630/ |
id |
pubmed-4430630 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-44306302015-06-10 Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma Taioli, Emanuela Wolf, Andrea S. Moline, Jacqueline M. Camacho-Rivera, Marlene Flores, Raja M. Research Article Introduction. Malignant Pleural Mesothelioma (MPM) is a rare disease, even less frequently described in minority patients. We used a large population-based dataset to study the role of race in MPM presentation, treatment, and survival. Methods. All cases of pathologically proven MPM were identified in the Surveillance, Epidemiology, and End Results (SEER) database. Age, sex, diagnosis year, stage, cancer-directed surgery, radiation, and vital status were analyzed according to self-reported race (black or white). Results. There were 13,046 white and 688 black MPM patients (incidence: 1.1 per 100,000 whites; 0.5 per 100,000 blacks; age-adjusted, p = 0.01). Black patients were more likely to be female, younger, and with advanced stage and less likely to undergo cancer-directed surgery than whites, after adjustment by stage. On multivariable analysis, younger age and having surgery were associated with longer survival for both cohorts; female gender (HR 0.82 (0.77–0.88)) and early stage at diagnosis (HR 0.83 (0.76–0.90)) were predictive of longer survival in white, but not in black, patients. Conclusions. Surgery was associated with improved survival for both black and white MPM patients. However, black patients were less likely to undergo cancer-directed surgery. Increased surgical intervention in MPM black patients with early stage disease may improve their survival. Hindawi Publishing Corporation 2015 2015-04-30 /pmc/articles/PMC4430630/ /pubmed/26063951 http://dx.doi.org/10.1155/2015/282145 Text en Copyright © 2015 Emanuela Taioli et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Taioli, Emanuela Wolf, Andrea S. Moline, Jacqueline M. Camacho-Rivera, Marlene Flores, Raja M. |
spellingShingle |
Taioli, Emanuela Wolf, Andrea S. Moline, Jacqueline M. Camacho-Rivera, Marlene Flores, Raja M. Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma |
author_facet |
Taioli, Emanuela Wolf, Andrea S. Moline, Jacqueline M. Camacho-Rivera, Marlene Flores, Raja M. |
author_sort |
Taioli, Emanuela |
title |
Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma |
title_short |
Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma |
title_full |
Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma |
title_fullStr |
Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma |
title_full_unstemmed |
Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma |
title_sort |
frequency of surgery in black patients with malignant pleural mesothelioma |
description |
Introduction. Malignant Pleural Mesothelioma (MPM) is a rare disease, even less frequently described in minority patients. We used a large population-based dataset to study the role of race in MPM presentation, treatment, and survival. Methods. All cases of pathologically proven MPM were identified in the Surveillance, Epidemiology, and End Results (SEER) database. Age, sex, diagnosis year, stage, cancer-directed surgery, radiation, and vital status were analyzed according to self-reported race (black or white). Results. There were 13,046 white and 688 black MPM patients (incidence: 1.1 per 100,000 whites; 0.5 per 100,000 blacks; age-adjusted, p = 0.01). Black patients were more likely to be female, younger, and with advanced stage and less likely to undergo cancer-directed surgery than whites, after adjustment by stage. On multivariable analysis, younger age and having surgery were associated with longer survival for both cohorts; female gender (HR 0.82 (0.77–0.88)) and early stage at diagnosis (HR 0.83 (0.76–0.90)) were predictive of longer survival in white, but not in black, patients. Conclusions. Surgery was associated with improved survival for both black and white MPM patients. However, black patients were less likely to undergo cancer-directed surgery. Increased surgical intervention in MPM black patients with early stage disease may improve their survival. |
publisher |
Hindawi Publishing Corporation |
publishDate |
2015 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430630/ |
_version_ |
1613223094009200640 |